Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-24

FDA Approved: PLERIXAFOR — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a generic version of Plerixafor (Novadoz Pharmaceuticals LLC) under an Original Application (ANDA) for mobilizing hematopoietic stem cells in adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Plerixafor (Plerixafor)

Snippet

ORIG AP for PLERIXAFOR (PLERIXAFOR)